Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arrowhead Pharmaceuticals Inc shares valued at $583,692 were sold by Anzalone Christopher Richard on Apr 11 ’25. At $11.49 per share, Anzalone Christopher Richard sold 50,800 shares. The insider’s holdings dropped to 3,921,255 shares worth approximately $51.96 million following the completion of this transaction.
Also, Anzalone Christopher Richard sold 50,000 shares, netting a total of over 543,500 in proceeds. Following the sale of shares at $10.87 each, the insider now holds 3,972,055 shares.
Before that, Anzalone Christopher Richard had sold 40,322 shares from its account. In a trade valued at $406,145, the Chief Executive Officer traded Arrowhead Pharmaceuticals Inc shares for $10.07 each. Upon closing the transaction, the insider’s holdings decreased to 40,322 shares, worth approximately $53.29 million.
As published in their initiating research note from Goldman on June 05, 2024, Arrowhead Pharmaceuticals Inc [ARWR] has been a Neutral and the price target has been revised to $31. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of September 19, 2023, Citigroup has initiated its “Neutral” rating for ARWR. Earlier on July 21, 2023, TD Cowen initiated its rating. Their recommendation was “an Outperform” for ARWR stock.
Analyzing ARWR Stock Performance
During the last five days, there has been a drop of approximately -5.63%. Over the course of the year, Arrowhead Pharmaceuticals Inc shares have dropped approximately -29.52%. Shares of the company reached a 52-week high of $21.84 on 02/07/25 and a 52-week low of $9.57 on 04/07/25. A 50-day SMA is recorded $13.98, while a 200-day SMA reached $19.51.
Support And Resistance Levels for Arrowhead Pharmaceuticals Inc (ARWR)
According to the 24-hour chart, there is a support level at 12.63, which, if violated, would cause prices to drop to 12.01. In the upper region, resistance lies at 13.68. The next price resistance is at 14.11. RSI (Relative Strength Index) is 49.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.21, which suggests the price will decrease in the coming days. Percent R is at 42.79%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
